Q2 2025 Medtronic PLC Earnings Call Transcript
Key Points
- Medtronic PLC (MDT) reported a strong quarter with 5% organic revenue growth, translating into 8% EPS growth on a constant currency basis.
- The company raised its full-year revenue and EPS guidance, marking eight consecutive quarters of mid-single-digit organic revenue growth.
- Strong performance was noted in key franchises such as TAVR, PFA, leadless pacemakers, diabetes, spine, and neuromodulation.
- Medtronic PLC (MDT) is making significant progress in its hypertension management with the Symplicity blood pressure procedure, supported by CMS's transitional pass-through payment.
- The company is actively investing in its pipeline and emerging growth drivers, including surgical robotics and digital solutions, to ensure future growth.
- Medtronic PLC (MDT) faced a supply chain disruption due to a third-party component supplier interruption, affecting the growth of its PulseSelect PFA catheter.
- The company is experiencing foreign currency headwinds, impacting its gross and operating margins.
- Despite strong growth in some areas, the medical surgical portfolio showed low single-digit growth due to difficult year-over-year comparisons and market slowdowns.
- There are concerns about the potential impact of tariffs and geopolitical factors on the supply chain, particularly regarding imports from China.
- The early stages of product launches like Hugo and Affera may initially present a mix headwind, affecting margins.
(video playing)
Good morning. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations, and I appreciate that you're joining us for our fiscal '25 second-quarter video earnings webcast.
Before we go inside to hear our prepared remarks, I'll share a few details about today's webcast. Joining me are Geoff Martha, Chairman and Chief Executive Officer; and Gary Corona, Interim Chief Financial Officer. Geoff and Gary will provide comments on the results of our second quarter. After our prepared remarks, the executive VPs from each of our four segments will join us, and we'll take questions from the sell-side analysts that cover the company. Today's program should last about an hour.
Earlier this morning, we issued a press release containing our financial statements, divisional and geographic revenue summaries, and non-GAAP reconciliations. We also posted an earnings presentation that provides additional details on our performance. The presentation can be accessed in our earnings press
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
